{"id":"W3025838847","doi":"10.1038/s41593-020-0628-4","title":"RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma","year":2020,"lang":"en","type":"article","venue":"Nature Neuroscience","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":41,"is_retracted":true,"has_abstract":false,"ca_institutions":"University of Calgary; Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children","funders":"National Cancer Institute; Canadian Institutes of Health Research; U.S. Department of Health and Human Services; Center for Scientific Review; American Brain Tumor Association; Stand Up To Cancer; California Dental Association Foundation; Brain Tumour Charity; Sparks; National Institute of Allergy and Infectious Diseases; Medical Research Council; CureSearch for Children's Cancer; Cancer Research UK; Accelerate Brain Cancer Cure; Massachusetts Department of Fish and Game; V Foundation for Cancer Research; Deutsche Forschungsgemeinschaft; Government of Canada; Alex's Lemonade Stand Foundation for Childhood Cancer; Division of Cancer Epidemiology and Genetics, National Cancer Institute; St. Baldrick's Foundation; California Institute for Regenerative Medicine; Pediatric Cancer Research Foundation; National Institutes of Health","keywords":"Major histocompatibility complex; Tumor necrosis factor alpha; Cytotoxic T cell; MHC class I; Immune system; Biology; Cancer research; Immunotherapy; Immunology; Immune checkpoint; In vitro","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Results Not Reproducible;Unreliable Data;Unreliable Results and/or Conclusions;","date":"12/14/2021 0:00","openalex_flagged":true},"screen":null}